Synthesis and characterization of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-labeled fluorescent ligands for the mu opioid receptor

Biochemical Pharmacology

Volumn 54, Issue 12, 1997, Pages 1315-1322

  Emmerson, Paul J ^a   Archer, Sydney ^b   El Hamouly, Wageeh ^b   Mansour, Alfred ^a   Akil, Huda ^a   Medzihradsky, Fedor ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Research Rensselaer Polytechnic Institute   (United States)

Author keywords

BODIPY; Fluorescence; Mu opioid receptor; Receptor binding

Indexed keywords

FLUORESCENT DYE; LIGAND; MU OPIATE RECEPTOR; NALTREXAMINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG SYNTHESIS; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; GENE EXPRESSION; GENE TRANSFER; GLIOMA CELL; IN VITRO STUDY; MONKEY; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALS; BORON COMPOUNDS; FLUORESCENT DYES; GLIOMA; NARCOTICS; RATS; RECEPTORS, OPIOID, MU; TUMOR CELLS, CULTURED;

EID: 0030704260     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00374-2     Document Type: Article

References (39)

1. Carraway KL, Cerione RA. Fluorescent-labeled growth factor molecules serve as probes for receptor binding and exocytosis. Biochemistry. 32:1993;12039-12045.
2. Fay SP, Posner RG, Swann WN, Sklar LA. Real-time analysis of the assembly of ligand, receptor, and G protein by quantitative fluorescence flow cytometry. Biochemistry. 30:1991;5066-5075.
3. Tota MR, Daniel S, Sirotina A, Mazina KE, Fong TM, Longmore J, Strader CD. Characterization of a fluorescent substance P analog. Biochemistry. 33:1994;13079-13086.
4. Srinivasan Y, Guzikowski AP, Haugland RP, Angelides KJ. Distribution and lateral mobility of glycine receptors on cultured spinal cord neurons. J Neurosci. 10:1990;985-995.
5. Uhlen S, Axelrod D, Keefer JR, Limbird LE, Neubig RR. Membrane organization and mobility of α2 adrenergic receptors in MDCK cells. Pharmacol Commun. 6:1995;155-167.
6. Pavo I, Jans DA, Peters R, Penke B, Farenholz F. Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells. Biochim Biophys Acta. 1223:1994;240-246.
7. Kwon G, Axelrod D, Neubig RR. Lateral mobility of tetramethylrhodamine (TMR) labelled G protein alpha and beta-gamma subunits in NG 108-15 cells. Cell Signal. 6:1994;663-679.
8. Carraway KL, Koland JG, Cerione RA. Location of the epidermal growth factor binding site on the EGF receptor. A resonance energy transfer study. Biochemistry. 29:1990;8741-8747.
9. Wang S, Martin E, Cimino J, Omann G, Glaser M. Distribution of phospholipids around gramacidin and D-β-hydroxybutyrate dehydrogenase as measured by resonance energy transfer. Biochemistry. 27:1988;2033-2039.
10. Shahrokh Z, Verkman AS, Shoet SB. Distance between skeletal muscle protein 4.1 and the erythrocyte membrane bilayer measured by resonance energy transfer. J Biol Chem. 266:1991;12082-12089.
11. Hazum E, Chang KJ, Shecter Y, Wilkinson S, Cuatrecasas P. Fluorescent and photo-affinity enkephalin derivatives Preparation and interaction with opiate receptors . Biochem Biophys Res Commun. 88:1979;841-846.
12. Hazum E, Chang KJ, Cuatrecasas P. Opiate (enkephalin) receptors of neuroblastoma cells Occurrence in clusters on the cell surface . Science. 206:1979;1077-1079.
13. Blanchard SG, Chang KJ, Cuatrecasas P. Visualization of enkephalin receptors by image-intensified fluorescence microscopy. Methods Enzymol. 103:1983;219-227.
14. Fournie-Zaluski MC, Gacel G, Roques BP, Senault B, Lecomte JM, Malfroy B, Swerts JP, Schwartz JC. Fluorescent enkephalin derivatives with biological activity. Biochem Biophys Res Commun. 83:1978;300-305.
15. Kolb VM, Koman A, Terenius L. Fluorescent probes for opioid receptors. Life Sci. 33:1983;423-426.
16. Archer S, Medzihradsky F, Seyed-Mozaffari A, Emmerson PJ. Synthesis and characterization of 7-nitrobenzo-2-oxa-1,3-diazole (NBD)-labeled fluorescent opioid. Biochem Pharmacol. 43:1992;301-306.
17. Mihara H, Lee S, Shimohigashi Y, Aoyagi H, Kato T, Izumiya N, Costa T. δ and μ Opioid receptor probes Fluorescent enkephalins with high receptor affinity and specificity . FEBS Lett. 193:1985;35-38.
18. Glasel JA, Venn RF. The sensitivity of opiate receptors and ligands to short wavelength ultraviolet light. Life Sci. 29:1981;221-228.
19. Lawrence DMP, El-Hamouly W, Archer S, Leary JF, Bidlack JM. Identification of κ opioid receptors in the immune system by indirect immunofluorescence. Proc Natl Acad Sci USA. 92:1995;1062-1066.
20. Chang A-C, Chao CC, Takemori AE, Gekker G, Hu S, Peterson PK, Portoghese PS. Arylacetamide-derived fluorescent probes Synthesis, biological evaluation, and direct fluorescent labeling of κ opioid receptors in mouse microglial cells . J Med Chem. 39:1996;1729-1735.
21. Heithier H, Hallmann D, Boege F, Reiländer H, Dees C, Jaeggi KA, Arndt-Jovin D, Jovin TM, Helmreich EJM. Synthesis and properties of fluorescent β-adrenoceptor ligands. Biochemistry. 33:1994;9126-9134.
22. Barton AC, Kang HC, Rinaudo MS, Monsma FJ, Stewart-Fram RM, Macinko JA, Haugland RP, Ariano MA, Sibley DR. Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity. Brain Res. 547:1991;199-207.
23. Thompson RC, Mansour A, Akil H, Watson SJ. Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron. 11:1993;903-913.
24. 6 glioma cell line expressing the μ opioid receptor. J Pharmacol Exp Ther. 278:1996;1121-1127.
25. Emmerson PJ, Archer S, El-Hamouly W, Mansour A, Akil H and Medzihradsky F, Labeling of the mu opioid receptor with a newly developed fluorescent ligand. J Neurochem 64 (Suppl): S104C, 1995.
26. Sebastian A, Bidlack JM, Jiang Q, Deecher D, Teitler M, Glick SD, Archer S. 14β-[(p-Nitrocinnamoyl)amino]morphinones, 14β-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues Synthesis and receptor activity . J Med Chem. 36:1993;3154-3160.
27. Cahill AL, Medzihradsky F. Interaction of central nervous system drugs with synaptosomal transport processes. Biochem Pharmacol. 25:1976;2257-2264.
28. Emmerson PJ, Liu MR, Woods JH, Medzihradsky F. Binding affinity and selectivity of opioids at mu, delta, and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther. 271:1994;1630-1637.
29. 50) of an enzymatic reaction. Biochem Pharmacol. 22:1973;3099-3108.
30. Heithier H, Jaeggi KA, Ward LD, Cantrill RC, Helmreich EJM. Synthesis and characterization of CGP-12177-NBD A fluorescent beta-adrenergic receptor probe . Biochimie. 70:1988;687-694.
31. McLaughlin JP, Sebastian A, Archer S, Bidlack JM. 14β-Chlorocinnamoylamino derivatives of metopon Long-term μ-opioid receptor antagonists . Eur J Pharmacol. 320:1997;121-129.
32. Davis RP, Canessa-Fischer M. Spectrofluorometric identification of reduced pyridine nucleotide in the intact isolated urinary bladder of the toad. Anal Biochem. 10:1965;325-343.
33. Aubin JE. Autofluorescence of viable cultured mammalian cells. J Histochem Cytochem. 27:1979;36-43.
34. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955.
35. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. The δ-opioid receptor Isolation of a cDNA by expression cloning and pharmacological characterization . Proc Natl Acad Sci USA. 89:1992;12048-12052.
36. Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, Bell GI. Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc Natl Acad Sci USA. 90:1993;6736-6740.
37. Meng F, Xie G-X, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H. Cloning and pharmacological characterization of a rat κ opioid receptor. Proc Natl Acad Sci USA. 90:1993;9954-9958.
38. Chen Y, Mestek A, Liu J, Hurley JA, Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol. 44:1993;8-12.
39. Remmers AE, Medzihradsky F. Reconstitution of high-affinity opioid agonist binding in brain membranes. Proc Natl Acad Sci USA. 88:1991;2171-2175.